Alto Neuroscience, Inc. Liabilities and Equity in USD from Q4 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Alto Neuroscience, Inc. quarterly Liabilities and Equity history and growth rate from Q4 2023 to Q3 2025.
  • Alto Neuroscience, Inc. Liabilities and Equity for the quarter ending September 30, 2025 was $147M, a 23.3% decline year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)

Alto Neuroscience, Inc. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $147M -$44.6M -23.3% Sep 30, 2025 10-Q 2025-11-12
Q2 2025 $158M -$39.5M -20% Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $172M -$38M -18.1% Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $178M +$90.9M +105% Dec 31, 2024 10-Q 2025-11-12
Q3 2024 $192M Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $197M Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $210M Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $86.6M Dec 31, 2023 10-K 2025-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.